Registry of Lobbyists
Total Number of Communication Reports: 0
Monthly communication reports in the last 6 months: 0
| Subject matters | Details | Categories |
|---|---|---|
|
Health, Research and Development
|
Engagement with officials on federal policies to ensure timely access to treatments for rare disorders, including pulmonary arterial hypertension, and to promote research and development related to treatments for rare disorders.
|
Policies or Program
|
|
Health
|
Engagement with officials regarding the implementation of the National Strategy on Drugs for Rare Diseases.
|
Policies or Program
|
|
Health
|
Raise awareness among parliamentarians and government officials regarding pulmonary arterial hypertension, a rare disorder characterized by high blood pressure (hypertension) in the arteries of the lungs.
|
Policies or Program
|
End date of the last completed financial year: 2023-12-31
| Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
|---|---|---|
| Employment and Social Development Canada (ESDC) | $22,000.00 | No |
Address:
408- 55 Water Street
Office 8928
Vancouver, BC V6B 1A1
Canada
Telephone number:
604-682-1036
Web address:
https://phacanada.ca/Home
Jamie Myrah, Executive Director
Pulmonary Hypertension Association of Canada is not a subsidiary of any other parent companies.
Pulmonary Hypertension Association of Canada is not a coalition.
The activities of Pulmonary Hypertension Association of Canada are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Pulmonary Hypertension Association of Canada does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Stephanie Levee | Public offices held
Firm: 3Sixty Public Affairs Inc.